ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Catheter site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3,1,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
4,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
6,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
7,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
7,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
8,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
9,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
9,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
10,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
12,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
12,3,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
12,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
13,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
14,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
14,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
15,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
16,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
17,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
17,2,Carbohydrate antigen 19-9 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
17,3,Carcinoembryonic antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
17,4,Hepatic mass,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
17,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
18,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
18,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
18,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
18,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
18,5,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
18,6,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
18,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,8,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
19,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
19,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
19,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
19,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
19,5,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
19,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
19,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
19,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
20,1,BRAF gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
20,2,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
21,1,BRAF gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
21,2,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
22,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
22,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,6,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
23,1,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
23,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
23,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
23,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
23,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
23,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
23,7,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
23,8,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
23,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
23,10,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
23,11,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
23,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,13,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,1,Coronary artery embolism,Coronary artery disorders NEC,Coronary artery disorders,Card,N
24,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
25,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
26,1,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
26,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
26,3,Metastases to retroperitoneum,Metastases to specified sites,Metastases,Neopl,N
26,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
26,5,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
27,1,Eyelid exfoliation,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
27,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
29,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
29,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
29,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
30,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
31,1,Metastases to ovary,Metastases to specified sites,Metastases,Neopl,N
32,1,Metastases to ovary,Metastases to specified sites,Metastases,Neopl,N
33,1,Metastases to ovary,Metastases to specified sites,Metastases,Neopl,N
34,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
36,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
36,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
36,3,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
36,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
37,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
38,1,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
39,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
39,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
40,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
41,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
41,2,Eye infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
41,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
42,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
42,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
42,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
42,4,Rectal adenocarcinoma,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
42,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
42,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
43,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
43,2,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
43,3,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
43,4,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
43,5,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
43,6,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
43,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
43,8,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
43,9,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
43,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
43,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
43,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
43,13,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
43,14,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
43,15,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
43,16,Staphylococcal skin infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
43,17,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
44,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
44,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
45,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
46,1,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
46,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
47,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
47,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
48,1,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
48,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
49,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
49,3,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
49,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
49,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
49,6,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
49,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
49,8,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
49,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
49,10,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
49,11,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
49,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
49,13,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
49,14,Osteosclerosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
49,15,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
49,16,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
49,17,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
49,18,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
49,19,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
49,20,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,21,Self esteem decreased,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
49,22,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
49,23,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
49,24,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
49,25,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
50,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
51,1,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
51,2,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
51,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
53,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
53,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
55,1,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
56,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
56,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
56,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
57,1,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
57,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
58,1,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
58,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
58,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
59,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
59,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
59,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
59,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,6,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
59,8,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
59,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
61,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
62,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
62,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
62,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
62,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
63,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
65,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
66,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
67,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
67,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
68,1,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
69,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
70,1,Psychological trauma,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
70,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
71,1,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
71,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
71,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
73,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
73,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
73,3,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
74,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
75,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
75,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
76,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
77,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
78,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
80,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
80,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
80,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
81,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
81,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
81,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
81,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
81,8,Headache,Headaches NEC,Headaches,Nerv,N
81,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
81,11,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
81,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
81,13,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
83,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
83,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
84,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
85,1,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
85,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
86,1,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
87,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
87,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
88,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
89,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
89,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
90,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
90,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
91,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
93,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
94,1,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
95,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
96,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
97,1,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
97,2,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
97,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
98,1,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
98,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
99,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
99,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
99,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
100,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
100,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
102,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
102,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
102,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
103,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
103,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
103,3,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
104,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
104,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
105,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
105,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
105,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
106,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
107,1,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
108,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
109,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
110,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
111,1,Blood magnesium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
111,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
112,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
113,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
113,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
114,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
114,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
115,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
116,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
116,2,Neurosarcoidosis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
116,3,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
117,1,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
117,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
118,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
118,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
118,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
118,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
118,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
118,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
118,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
119,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
119,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
119,3,Lymphangitis,Vascular infections,Infections - pathogen unspecified,Infec,N
120,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
121,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
122,1,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
123,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
123,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
124,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
124,2,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
124,3,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
124,4,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
124,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
124,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
124,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
125,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
126,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
127,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
127,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
127,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
128,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
129,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
129,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
130,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
131,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
132,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
132,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
133,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,1,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
134,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
135,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
135,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
135,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
136,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
136,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
137,1,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
137,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
138,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
138,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
139,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
139,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
139,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
140,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
140,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
140,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
140,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
141,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
142,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
143,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
144,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
144,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
144,3,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
144,4,Myocardial fibrosis,Myocardial disorders NEC,Myocardial disorders,Card,N
144,5,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
145,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
145,2,Trichomegaly,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
